Anlotinib+Cadonilimab+PULSAR in Advanced Biliary Tract Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Anlotinib+Cadonilimab+PULSAR in Advanced Biliary Tract Cancer	Biliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, biliary tract cancer, biliary tract disorder, neoplasm	Active, not recruiting	Phase 2	2026-06-09		NCT07635290

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Akeso	89
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	88
West China Hospital	359

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
West China Hospital, Sichuan University	Chengdu	China	129

Clinical trials